VectivBio Holding AG Increase Decrease Through Financing Cash Flows Liabilities Arising From Financing Activities
VectivBio Holding AG reported Increase Decrease Through Financing Cash Flows Liabilities Arising From Financing Activities of -$9.53 million for the 12-month period ending 2022-12-31, per its 20-F filed 2023-04-19.
Discontinued › Cash Flow › Operating Activities
ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities · last filed 2023-04-19
| Period end | Increase Decrease Through Financing Cash Flows Liabilities Arising From Financing Activities 12 month | Increase Decrease Through Financing Cash Flows Liabilities Arising From Financing Activities 12 month as first filed |
|---|---|---|
| 2022-12-31 | -$9.53M 20-F · filed 2023-04-19 | |
| 2021-12-31 | $135.00K 20-F · filed 2023-04-19 | -$134.00K 20-F · filed 2022-04-07 |
| 2020-12-31 | -$2.78M 20-F · filed 2023-04-19 | $2.78M 20-F · filed 2022-04-07 |
| 2019-12-31 | $16.98M 20-F · filed 2022-04-07 |